Over the decades, scientists have revealed many strategies that keep normal cells from becoming cancerous. Understanding natural anti-tumor processes could help researchers develop better approaches ...

(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder cancer and only modestly extended the lives of previously treated patients with late-stage lung ...

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term ...

In May, surgeons at the University of Southern California and the University of California, Los Angeles, collaborated to perform the world's first human bladder transplant. Currently, when a bladder ...

In May, surgeons at USC and UCLA collaborated to perform the world’s first-in-human bladder transplant. Currently, when a bladder fails or needs to be removed, doctors create a “neobladder” using a ...

June 27 (Reuters) - Aquinox Pharmaceuticals Inc said on Wednesday its treatment for bladder pain syndrome failed to meet the main goal of a late-stage trial, and the company plans to stop developing ...

Sanofi Pasteur said it’s discontinuing the manufacture of TheraCys, an important bladder cancer drug, and shortages are expected, while the US Food and Drug Administration (FDA) on Friday released ...

The FDA has approved Inlexzo, the first intravesical drug-releasing device for bladder cancer, offering an alternative for patients whose disease no longer responds to BCG therapy. The device delivers ...